The biggest difference between kids and adults, in my mind, is that kids bodies and brains are still growing
But what's different with GLP-1 users is that the skin changes are often more rapid and dramatic and theres a broader demographicnot just older womenusing these medications. Sometimes the marketing moves faster than the science
Semaglutide has a well-established safety profile in people with T2D and obesity, including in people aged 65 years and older, suggesting that it will be well tolerated in the evoke/evoke+ populations with early AD [15, 27, 41,42,43,44, 57, 58, 63]
The robust postprandial GLP-1 response observed in our cohort, particularly at one year post-surgery, is consistent with Dimitriadis et al